About us
- >
- About us >
- Information >
- Announcement
2019-03-05
The US patent of treating Alzheimer's disease and Diabetes is granted
The US patent, treating Alzheimer's disease and Diabetes, is granted (13/859,741). The patent covers the medical indications using the ENRGI platform, such as treatments of Alzheimer's disease, pre-diabetes, type 2 diabetes, and metabolic disorders.